Business Intelligence
Insurer is engaging in a request for proposals for a new pharmacy benefit manager following the end of its contract.
United States Court of Appeals is currently considering Anthem's appeal of a district court ruling in February blocking the merger.
Alaska and Minnesota have seen double-digit increases in ACA plan premiums this year have already moved to implement reinsurance policies.
Hispanics' share of the population is expected to widen from nearly a fifth now to a quarter by 2045.
Leaders consistently included shortages and drug pricing among their top concerns in the survey over the last two years.
Group asks to meet with president to pitch replacement plan to the Affordable Care Act.
Country has grown increasingly dependent on the health sector to power the economy as Obamacare helped boost job growth, experts say.
Patent laws, government incentives, meant to encourage development of less-profitable drugs, enable some companies to get a leg up, set high prices.
Congressional records show those eight, including Celgene and Mylan, kicked in an extra $4.42 million versus that quarter last year.
News of Marathon's resignation comes after wide criticism for $89,000 price tag for Emflaza, a drug for Duchenne muscular dystrophy drug.